Alivus Life Sciences Limited
ALIVUSPharmaceuticals
Glenmark Life Sciences, a subsidiary of Glenmark Pharmaceuticals Ltd, is one of the leading developers and manufacturers of select high-value Active Pharmaceutical Ingredients. The company further operates in Contract Development and manufacturing operations to offer services to specialty Pharmaceutical companies.
131Announcements
11-09-2026Last filed
25Last 90 days
What Alivus files
- Investor Meet54
- Others29
- Updates18
- Important9
- Board Meeting8
- PPTs7
Showing QIP/Rights/Pref. announcements (1)Clear filter
01-08-2025 · 06:38 pm
Alivus Life Sciences has allotted 52,200 Equity Shares, each with a face value of Rs. 2, to eligible employees who exercised their stock options. This move increases the company's paid-up share capital from 12,26,29,148 equity shares (aggregating Rs. 24,52,58,296) to 12,26,81,348 equity shares (aggregating Rs. 24,53,62,696). This slight increase in...